Por favor, inténtelo con una nueva búsqueda
Símbolo | Mercado | Divisa | ||
---|---|---|---|---|
NBSE | NASDAQ | USD | Tiempo real | |
O7P | Stuttgart | EUR | Con demora | |
O7P | Frankfurt | EUR | Con demora |
Nombre | Edad | Desde | Título |
---|---|---|---|
Robert Zamboni | - | - | Chief of Preclinical Development & Member of Scientific Advisory Board |
Dov A. Goldstein | 55 | 2019 | Independent Chairperson |
George McDonald Church | 69 | 2023 | Chairperson of Gene Editing Advisory Board & Member of Scientific Advisory Board |
James M. Coull | - | 2023 | Member of Gene Editing Advisory Board |
Eric I. Richman | 62 | 2019 | Independent Director |
Robert Friedlander | - | - | Chair of Scientific Advisory Board |
Peter Nielsen | - | 2020 | Member of Gene Editing & Scientific Advisory Board |
Randy Davis | - | 2020 | Member of Scientific Advisory Board |
Eriks Rozners | - | 2020 | Member of Gene Editing & Scientific Advisory Board |
Gerald J. Mcdougall | 56 | 2021 | Independent Director |
Danith H. Ly | - | 2019 | Member of Advisory Board |
Steven F. Dowdy | - | 2019 | Member of Gene Editing & Scientific Advisory Board |
Jeremy Stark | - | 2023 | Member of Gene Editing Advisory Board |
Dietrich A. Stephan | 54 | 2019 | Founder, President & Director |
¿Está seguro de que desea bloquear a %USER_NAME%?
Al hacerlo, ni usted ni %USER_NAME% podrán ver las publicaciones del otro en Investing.com.
Se ha agregado correctamente a %USER_NAME% a su lista de usuarios bloqueados
Acaba de desbloquear a esta persona; tiene que esperar 48 horas para poder bloquearla de nuevo.
Díganos qué piensa de este comentario
Gracias
Su denuncia será examinada por nuestros moderadores